Search Results - Cho-Phan, Cheryl

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Understanding Racial and Ethnic Inequities in Uptake and Outcomes Following Multigene Prognostic Testing in Early Breast Cancer: The Promise of Real-World Data

    Understanding Racial and Ethnic Inequities in Uptake and Outcomes Following Multigene Prognostic Testing in Early Breast Cancer: The Promise of Real-World Data by Wang, Xiaoliang, Cho-Phan, Cheryl D, Hoskins, Kent F, Calip, Gregory S

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    RAS Amplification as a Negative Predictor of Benefit from Anti‐EGFR–Containing Therapy Regimens in Metastatic Colorectal Cancer

    RAS Amplification as a Negative Predictor of Benefit from Anti‐EGFR–Containing Therapy Regimens in Metastatic Colorectal Cancer by Schrock, Alexa B., Lee, Jessica K., Sandhu, Jaideep, Madison, Russell, Cho‐Phan, Cheryl, Snider, Jeremy W., Castellanos, Emily, Venstrom, Jeffrey M., Fakih, Marwan

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Long-Term Survival of a Patient With Non–Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene

    Long-Term Survival of a Patient With Non–Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene by Myall, Nathaniel J, Neal, Joel W, Cho-Phan, Cheryl D, Zhou, Lisa Y, Stehr, Henning, Zhou, Li, Diehn, Maximilian, Wakelee, Heather A

    Published in Clinical lung cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    The Development Of RRx-001, A Novel Nitric-Oxide-Mediated Epigenetically Active Anticancer Agent

    The Development Of RRx-001, A Novel Nitric-Oxide-Mediated Epigenetically Active Anticancer Agent by Scicinski, Jan, Fisher, George, Carter, Corey, Cho-Phan, Cheryl, Kunz, Pamela, Ning, Shoucheng, Knox, Susan, Oronsky, Bryan, Caroen, Scott, Parker, Christopher, Fanger, Gary, Reid, Tony

    Published in Redox biology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Abstract 864: Changes over time in real-world next-generation sequencing (NGS) test use in patients (pts) with advanced non-small cell lung cancer (aNSCLC)

    Abstract 864: Changes over time in real-world next-generation sequencing (NGS) test use in patients (pts) with advanced non-small cell lung cancer (aNSCLC) by Swaminathan, Akshay, Stergiopoulos, Stella, Snider, Jeremy, Fisher, Virginia, Castellanos, Emily, Snow, Tamara, Cho-Phan, Cheryl, Comment, Leah, Cunningham, Rachel, McCusker, Margaret E.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Abstract CT086: Pneumonitis incidence in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy in clinical trials and real-world data

    Abstract CT086: Pneumonitis incidence in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy in clinical trials and real-world data by Liu, Qi, Zhang, Chenan, Gong, Yutao, Zhu, Hao, Chang, Elaine, Cho-Phan, Cheryl, Hirsch, Jonathan, Thompson, Michael A., Blumenthal, Gideon, Huang, Shiew Mei, Brown, Thomas D.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Abstract 4257: Using Multilevel Regression and Poststratification (MRP) to inform estimates of biomarker prevalence for target populations of interest using linked clinico-genomic databases

    Abstract 4257: Using Multilevel Regression and Poststratification (MRP) to inform estimates of biomarker prevalence for target populations of interest using linked clinico-genomic... by Snider, Jeremy W., Beal, Brennan, Bouzit, Lilia, Cho-Phan, Cheryl, Comment, Leah, Frampton, Garrett, Snow, Tamara

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Abstract B26: RRx-001, a novel epigenetic modulator: Resensitization to previously failed therapy in the ongoing phase 2 colorectal cancer study, ROCKET

    Abstract B26: RRx-001, a novel epigenetic modulator: Resensitization to previously failed therapy in the ongoing phase 2 colorectal cancer study, ROCKET by Reid, Tony, Fisher, George, Carter, Corey, Cho-Phan, Cheryl, Kunz, Pamela, Oronsky, Bryan, Fanger, Gary, Stirn, Meaghan, Caroen, Scott, Parker, Christopher, Scicinski, Jan

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Abstract CT119: Early results from a phase II study of RRx-001, a novel, triple epigenetic inhibitor, showing resensitization to irinotecan in colorectal cancer

    Abstract CT119: Early results from a phase II study of RRx-001, a novel, triple epigenetic inhibitor, showing resensitization to irinotecan in colorectal cancer by Reid, Tony, Fisher, George, Carter, Corey, Cho-Phan, Cheryl, Kunz, Pamela, Oronsky, Bryan, Fanger, Gary R., Caroen, Scott, Parker, Christopher, Scicinski, Jan

    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Abstract A1-35: RRx-001, a novel first in class epigenetic modulator, “episensitizes” colorectal patients to FOLFIRI: Preliminary resensitization data from the Phase 2 “ROCKET” study

    Abstract A1-35: RRx-001, a novel first in class epigenetic modulator, “episensitizes” colorectal patients to FOLFIRI: Preliminary resensitization data from the Phase 2 “ROCKET” stu... by Reid, Tony, Carney, Jennifer, Beale, Keola, Clayton, Chan, Nguyen, Huy, Cho-Phan, Cheryl, Stirn, Meaghan, Ning, Shoucheng, Knox, Susan, Oronsky, Bryan, Scicinski, Jan, Caroen, Scott, Parker, Christopher, Fanger, Gary R., Fisher, George

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: